Biomarkers in Clinical Trials--SMi Conference. 23-24 September 2009, London, UK.
The Biomarkers in Clinical Trials conference, held in London, included topics covering new developments in the field of biomarkers. This conference report highlights selected presentations on the definition of biomarkers, the use of biomarkers to support decisions in drug development and to improve treatment outcomes, and the aims of the Biomarkers Consortium. A case study of the investigational drug selumetinib (AstraZeneca plc) is also discussed.
Walker
Glenda
G
Thomson Reuters, Hatton Garden, London, EC1N 8JS, UK. glenda.walker@thomsonreuters.com
D054316:Biomarkers, Pharmacological / Q000378:metabolism*; D002986:Clinical Trials as Topic; D003657:Decision Making; D015195:Drug Design; D004345:Drug Industry / Q000379:methods; D015507:Drugs, Investigational / Q000494:pharmacology*; D006801:Humans; D016896:Treatment Outcome
D054316:Biomarkers, Pharmacological; D015507:Drugs, Investigational